Target Name: MIR1471
NCBI ID: G100302126
Review Report on MIR1471 Target / Biomarker Content of Review Report on MIR1471 Target / Biomarker
MIR1471
Other Name(s): MicroRNA 1471 | hsa-mir-1471 | microRNA 1471 | hsa-miR-1471 | MIRN1471

MIR1471: A Drug Target / Disease Biomarker

MIR1471, also known as interleukin-14 (IL-14), is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and hair. It is a key regulator of inflammation and has been implicated in a number of diseases, including autoimmune disorders, cancer, and obesity.

One of the most promising aspects of MIR1471 is its potential as a drug target. Several studies have shown that MIR1471 can be targeted with small molecules and antibodies, and that it has a favorable binding profile that makes it an attractive candidate for drug development.

One of the key features of MIR1471 is its ability to induce various types of immune responses. MIR1471 has been shown to activate T cells, which are a critical component of the immune system and play a key role in fighting off infections and cancer. In addition, MIR1471 has been shown to induce B cells, which are responsible for producing antibodies, and to enhance the production of natural killer cells, which are important for fighting off viruses and other pathogens.

These properties make MIR1471 an attractive candidate for vaccines and therapeutic treatments that target the immune system. MIR1471 has also been shown to be involved in a number of diseases and disorders, including obesity, type 2 diabetes, and cancer.

One of the key challenges in developing MIR1471 as a drug target is its complex structure. MIR1471 is a large protein with a number of potential binding sites, and it can be difficult to identify and target these sites. However, researchers have made significant progress in understanding the structure and function of MIR1471, and have identified several potential binding sites that could be targeted with small molecules and antibodies.

In addition to its potential as a drug target, MIR1471 also has a number of potential applications in cancer research. MIR1471 has been shown to be expressed in a variety of cancer types, including breast, ovarian, and prostate cancer. It has also been shown to be involved in the development and progression of cancer, and to inhibit the growth of cancer cells. These properties make MIR1471 an attractive candidate for cancer therapies that target the immune system.

Overall, MIR1471 is a protein that has a number of potential applications as a drug target and in cancer research. Its ability to induce immune responses and its potential involvement in a variety of diseases and disorders make it an attractive candidate for further study and development.

Protein Name: MicroRNA 1471

The "MIR1471 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1471 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210